The leukemia controversy in myeloproliferative disorders: Is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?
The leukemia controversy in myeloproliferative disorders: Is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?
复制标题
DOI：
10.1053/j.seminhematol.2004.02.006
复制
发表时间：
2004-04-01
影响因子：
3.6
通讯作者：
Barbui, T
中科院分区：
文献类型：
--
作者：
Barbui, T
